Global Robotic Biopsy Devices Market Outlook 2030

"The global robotic biopsy equipment/device market is likely to be valued at ~USD 500 million in 2021 and is expected to grow at a significant rate of ~14% during the forecast period 2022-2030. The key factors behind this growth are the increasing incidence of cancer and the increasing popularity of robotic systems for diagnosing this disease. Cancer cases are increasing rapidly worldwide. According to the UK Cancer Research Centre, there were approximately 17 million new cancer cases in 2018. The most common cancers reported were lung, breast, bowel and prostate cancer, accounting for 43% of all new cases. In addition, it is predicted that by 2040, there will be nearly 27.5 million new cases each year. Biopsy is one of the main and main tests to determine the stage of cancer. 

 

The image-guided test can only detect abnormal mass growth, but cannot distinguish whether the mass is cancerous. It can only be accurately detected by a biopsy. Therefore, as the global cancer burden increases, so does the demand for these procedures for diagnosing cancer. This in turn creates opportunities for robotic biopsy equipment.

 

 In addition, the increasing demand for minimally invasive surgery from patients and providers is driving market growth. For example, the traditional method of performing prostate biopsy involves more complications and longer hospital stays. However, by choosing robot-assisted equipment, experts can obtain samples of specific areas of any part of the prostate with high accuracy without disturbing the peripheral nerves. 

 

Robotic biopsy methods can even provide more details about the location of the lesion. This reduces the risk of puncture damage to nearby tissues or organs. In addition, regardless of the large number of samples required for diagnosis, the robot-assisted procedure only requires 2 to 3 skin punctures. Because of the less invasiveness, the risk of infection is also small, which will eventually lead to a better recovery of the patient. 

 

This in turn has increased the adoption of robotic procedures instead of traditional methods; however, the lack of medical professionals in developing countries, coupled with the high installation costs required for these robotic systems, may hinder market growth. Low-income countries cannot afford these expensive equipment because their health expenditures are lower than the global average health expenditure. Due to the low reimbursement rate, operations in these countries are still performed with manual instruments. As a result, many cancer cases are not diagnosed, leading to high cancer death rates in these countries.

 

 PRODUCT TYPE INFORMATION:

 According to the product type, the robotic biopsy equipment market is divided into systems, instruments, and accessories. In 2020, instruments and accessories accounted for the largest share of revenue at 55%. Due to the variety of biopsy instruments and accessories on the market, this market segment is experiencing unprecedented growth. In addition, as the number of biopsies increases, the number of instruments such as needles and brushes required to perform this procedure also increases. Each new procedure requires a new set of equipment to reduce the risk of infection. Therefore, the sales of instruments and accessories continue; however, the system part is expected to grow at the fastest rate during the forecast period. More and more robotics and medical device companies are engaged in the R&D and commercialization of medical robots, which is a major factor affecting the demand for robotic-assisted biopsy equipment. These companies see it as a profitable business due to continued automation in the healthcare sector and patients; demand for minimally invasive surgery. 

 

For example, XACT Robotics has developed XACT Robotics System, which is a robotic platform that performs image-guided percutaneous surgery. The product is expected to be available in the United States in 2019, and many robotic devices such as the Monarch Platform and Ion Endoluminal System will also be available soon.

 

APPLICATION INFORMATION: 

The global market of robotic biopsy equipment is divided into lung, brain, prostate and other biopsies according to different applications. In 2020, lung biopsy dominates the market and is expected to have the highest compound annual growth rate during the forecast period, at 13%. The increase in the incidence of lung cancer is the main factor driving market growth. According to the American Cancer Institute, approximately 2 million new cases were reported globally in 2018. Almost 90% of cases are caused by smoking. Non-smokers exposed to second-hand smoke and radon or air pollution have also reported lung cancer.

 

 REGIONAL INFORMATION: 

Based on geographic location, the robotic biopsy equipment market is segmented into North America, Europe, Asia Pacific, Latin America, and MEA. North America dominated the market in 2020, with revenues of ~USD 180 million. The presence of major players in the region, sound medical infrastructure, and continued investment in biopsy robots are some of the key factors affecting most parts of North America, which is constantly striving to achieve inclusiveness. Robots and other technology platforms are used for cancer diagnosis in healthcare environments. 

 

For example, in 2019, US-based Intuitive Surgical launched the Ion robotic platform for minimally invasive peripheral lung biopsy. The device is already on the market in the United States. In addition, California-based Auris Health has developed a flexible robotic endoscope system called the Monarch platform. The system is designed to detect lung nodules. The product was only launched in the United States. The commercialization of most robotic devices in the United States has also made the region a leader in robotic-assisted biopsy devices.

 

 MARKET SHARE INFORMATION ON ROBOTIC BIOPSY EQUIPMENT : 

The market for robotic-assisted biopsy equipment is essentially oligopolistic. Major market players are focusing on strategic integration to expand market coverage and gain greater share. Some of the main players are Medtronic plc, Renishaw plc, iSYS Medizintechnik GmbH, Mazor Robotics, Biobot Surgical Pte Ltd, Medrobotics and Medtech SA. Participants expected to enter the equipment market include Intuitive Surgical, Auris Health and XACT Robotics.

 

Market Segments Covered by the Report This report forecasts global, regional and national revenue growth, and analyzes the latest industry trends in each sub-segment from 2022-2030. For the purpose of this research, Kenneth has subdivided the global robotics industry. Biopsy equipment market report by product type, application and region: Product type outlook (revenue, millions of dollars, 2022-2030) system, instrument and accessory applications Prospects (income, millions of dollars, 2022-2030) Lung biopsy Brain biopsy Prostate biopsy Other biopsy"
 

Geography Analysis:

The report further discusses the market opportunity, compound annual growth rate (CAGR) growth rate, competition, new technology innovations, market players analysis, government guidelines, export and import (EXIM) analysis, historical revenues, future forecasts etc. in the following regions and/or countries:

• North America (U.S. & Canada) Market Size, Y-O-Y Growth, Market Players Analysis & Opportunity Outlook
• Latin America (Brazil, Mexico, Argentina, Rest of Latin America) Market Size, Y-O-Y Growth & Market Players Analysis & Opportunity Outlook
• Europe (U.K., Germany, France, Italy, Spain, Hungary, Belgium, Netherlands & Luxembourg, NORDIC(Finland, Sweden, Norway, Denmark), Ireland, Switzerland, Austria, Poland, Turkey, Russia, Rest of Europe), Poland, Turkey, Russia, Rest of Europe) Market Size, Y-O-Y Growth Market Players Analys  & Opportunity Outlook
• Asia-Pacific (China, India, Japan, South Korea, Singapore, Indonesia, Malaysia, Australia, New Zealand, Rest of Asia-Pacific) Market Size, Y-O-Y Growth & Market Players Analysis & Opportunity Outlook
• Middle East and Africa  (Israel, GCC (Saudi Arabia, UAE, Bahrain, Kuwait, Qatar, Oman), North Africa, South Africa, Rest of Middle East and Africa) Market Size, Y-O-Y Growth Market Players Analysis & Opportunity Outlook

.